Nobuhiro Hanai

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

<i>MECT1-MAML2</i> Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma

Mitsukuni Okabe, Satoru Miyabe, Hitoshi Nagatsuka et al. · Clinical Cancer Research · 2006 · 224 citations

Medicine, Oncology, Pathology +13

Biochemical and cell biological characterization of a mammalian septin, Sept11

Nobuhiro Hanai, Koh-ichi Nagata, Aie Kawajiri et al. · FEBS Letters · 2004 · 102 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma

Daisuke Nishikawa, Nobuhiro Hanai, Hidenori Suzuki et al. · ORL · 2018 · 81 citations

Medicine, Oncology, Radiation Oncology +17

<i><scp>MYB</scp></i>,<i><scp>MYBL</scp>1</i>,<i><scp>MYBL</scp>2</i> and <i><scp>NFIB</scp></i> gene alterations and <scp>MYC</scp> overexpression in salivary gland adenoid cystic carcinoma

Kana Fujii, Takayuki Murase, Shintaro Beppu et al. · Histopathology · 2017 · 74 citations

Medicine, Molecular Biology, Oncology +12